WallStSmart

Acme United Corporation (ACU)vsColgate-Palmolive Company (CL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Colgate-Palmolive Company generates 10150% more annual revenue ($20.80B vs $202.88M). CL leads profitability with a 10.0% profit margin vs 4.7%. ACU appears more attractively valued with a PEG of 1.54. CL earns a higher WallStSmart Score of 58/100 (C).

ACU

Buy

50

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 4.0Quality: 8.5
Piotroski: 5/9Altman Z: 3.97

CL

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 8.5Value: 4.7Quality: 5.5
Piotroski: 4/9Altman Z: 4.21
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACUSignificantly Overvalued (-36.1%)

Margin of Safety

-36.1%

Fair Value

$32.18

Current Price

$47.50

$15.32 premium

UndervaluedFair: $32.18Overvalued
CLUndervalued (+3.3%)

Margin of Safety

+3.3%

Fair Value

$98.33

Current Price

$93.39

$4.94 discount

UndervaluedFair: $98.33Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACU2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.9710/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

CL4 strengths · Avg: 9.3/10
Return on EquityProfitability
36.4%10/10

Every $100 of equity generates 36 in profit

Altman Z-ScoreHealth
4.2110/10

Safe zone — low bankruptcy risk

Market CapQuality
$73.67B9/10

Large-cap with strong market position

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Areas to Watch

ACU4 concerns · Avg: 3.3/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Market CapQuality
$186.48M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

CL4 concerns · Avg: 3.0/10
PEG RatioValuation
1.634/10

Expensive relative to growth rate

P/E RatioValuation
35.7x4/10

Premium valuation, high expectations priced in

Price/BookValuation
518.8x2/10

Trading at 518.8x book value

EPS GrowthGrowth
-5.9%2/10

Earnings declined 5.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : ACU

The strongest argument for ACU centers on Altman Z-Score, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : CL

The strongest argument for CL centers on Return on Equity, Altman Z-Score, Market Cap.

Bear Case : ACU

The primary concerns for ACU are PEG Ratio, Market Cap, Profit Margin. Thin 4.7% margins leave little buffer for downturns.

Bear Case : CL

The primary concerns for CL are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 54.99 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACU carries more volatility with a beta of 0.51 — expect wider price swings.

ACU is growing revenue faster at 13.8% — sustainability is the question.

CL generates stronger free cash flow (609M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CL scores higher overall (58/100 vs 50/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acme United Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Acme United Corporation supplies cutting, measuring, first aid, sharpening and safety products for the school, home, office, hardware, sporting goods and industrial markets in the United States, Canada, Europe and Asia. The company is headquartered in Shelton, Connecticut.

Colgate-Palmolive Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Colgate-Palmolive Company is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. It specializes in the production, distribution and provision of household, health care, personal care and veterinary products.

Visit Website →

Want to dig deeper into these stocks?